Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells

Published:2010-11 Issue:6 Volume:24 Page:424-435
ISSN:1674-8301
Container-title:Journal of Biomedical Research
language:en
Short-container-title:Journal of Biomedical Research

Author:

Cui Bo,Johnson Stewart P.,Bullock Nancy,Ali-Osman Francis,Bigner Darell D.,Friedman Henry S.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference48 articles.

1. Malignant gliomas in adults;Wen;N Engl J Med,2008

2. Drug Insight: temozolomide as a treatment for malignant glioma–impact of a recent trial;Mason;Nat Clin Pract Neurol,2005

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

4. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005

5. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents;Esteller;N Engl J Med,2000

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs;Expert Reviews in Molecular Medicine;2023

2. A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma;Cells;2021-12-02

3. Establishment of Patient-Derived Succinate Dehydrogenase–Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response;Clinical Cancer Research;2021-08-23

4. Targeted Regulation of Blood–Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma;ACS Applied Materials & Interfaces;2021-03-08

5. The interruption of atypical PKC signaling and Temozolomide combination therapy against glioblastoma;Cellular Signalling;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3